Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03084471
Brief Title: An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies. (STRONG)

First Submitted : March 7, 2017
First Submitted that Met QC Criteria : March 20, 2017
First Posted : March 21, 2017

Last Update Submitted that Met QC Criteria : September 19, 2019
Last Update Posted : September 20, 2019